Search
Patexia Research
Case number 2017-1366

Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 6, 2017 24 CORRECTED ENTRY: ORDER granting motion to terminate appeal [23] filed by Appellant Merck Sharp & Dohme Corp.; issuing mandate. Service as of this date by Clerk of Court. [422064] --[Edited 04/06/2017 by CB to revise docket text.] [CAB] [Entered: 04/06/2017 01:30 PM] (2)
Apr 3, 2017 23 MOTION of Appellant Merck Sharp & Dohme Corp. to terminate appeal through Dismissal. [Consent: unopposed]. Service: 04/03/2017 by email. [420938] [Joshua Davis] [Entered: 04/03/2017 01:10 PM] (6)
Mar 30, 2017 20 ORDER filed. The motion [17] is granted. The confidential and nonconfidential versions of Merck's opening brief are accepted for filing. Teva's response brief is due no later than May 25, 2017. Service: 03/30/2017 by clerk. [420379] [LMS] [Entered: 03/30/2017 03:24 PM] (2)
Mar 30, 2017 21 CONFIDENTIAL BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [18]. Number of Pages: 51. Service: 03/16/2017 by email. The paper copies of the brief should be received by the court on or before 04/06/2017. [420465] [CAB] [Entered: 03/30/2017 04:31 PM] (0)
Mar 30, 2017 22 BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [19]. Number of Pages: 51. Service: 03/16/2017 by email. Appellee's response brief is due no later than 05/25/2017. [420470] [CAB] [Entered: 03/30/2017 04:36 PM] (104)
Mar 16, 2017 17 CORRECTED ENTRY: MOTION of Appellant Merck Sharp & Dohme Corp. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/16/2017 by email. [416212]--[Edited 03/17/2017 by SJ - Reason: to add additional relief] [Nicolas Barzoukas] [Entered: 03/16/2017 01:32 PM] (23)
Mar 16, 2017 18 TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: CONFIDENTIAL OPENING BRIEF Service: 03/16/2017 by email. [416217] [Nicolas Barzoukas] [Entered: 03/16/2017 01:40 PM] (0)
Mar 16, 2017 19 TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: OPENING BRIEF. Service: 03/16/2017 by email. [416221] [Nicolas Barzoukas] [Entered: 03/16/2017 01:44 PM] (104)
Feb 10, 2017 16 **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [14] filed by Appellee Teva Pharmaceuticals USA, Inc. and Appellant Merck Sharp & Dohme Corp. Brief due 03/16/2017.; granting motion to extend time to file appellee's principal brief [14] filed by Appellee Teva Pharmaceuticals USA, Inc. and Appellant Merck Sharp & Dohme Corp. Brief due 05/25/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [406422] [SJ] [Entered: 02/10/2017 11:24 AM] (0)
Feb 9, 2017 15 Note to file: 17-1560 (COMP COMPANION started 02/09/2017) with 17-1366. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [405989] [17-1366, 17-1560] [JCA] [Entered: 02/09/2017 01:32 PM] (0)
Feb 6, 2017 14 MOTION of Appellant Merck Sharp & Dohme Corp. and Appellee Teva Pharmaceuticals USA, Inc. to extend the time to 03/16/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to extend the time to 05/25/2017 to Assuming Appellant's Brief is filed March 16, 2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/06/2017 by email. [405010] [Joshua Davis] [Entered: 02/06/2017 04:17 PM] (10)
Jan 30, 2017 13 Notice of intent to file corresponding briefs on CD-ROM for Appellant Merck Sharp & Dohme Corp. and Appellee Teva Pharmaceuticals USA, Inc.. Service: 01/30/2017 by email. [403217] [Joshua Davis] [Entered: 01/30/2017 06:23 PM] (3)
Dec 30, 2016 8 Entry of appearance for Joshua P. Davis as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395439] [Joshua Davis] [Entered: 12/30/2016 03:03 PM] (2)
Dec 30, 2016 9 Docketing Statement for the Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395440] [Joshua Davis] [Entered: 12/30/2016 03:05 PM] (3)
Dec 30, 2016 10 Certificate of Interest for the Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395441] [Joshua Davis] [Entered: 12/30/2016 03:06 PM] (3)
Dec 30, 2016 11 Entry of appearance for Lisa M. Thomas as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395442] [Lisa Thomas] [Entered: 12/30/2016 03:10 PM] (2)
Dec 30, 2016 12 Entry of appearance for Nicolas Barzoukas as principal counsel for Appellant Merck Sharp & Dohme Corp.. Service: 12/30/2016 by email. [395443] [Nicolas Barzoukas] [Entered: 12/30/2016 03:13 PM] (2)
Dec 21, 2016 2 Entry of appearance for Frederick H. Rein as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393250] [Frederick Rein] [Entered: 12/21/2016 03:15 PM] (2)
Dec 21, 2016 3 Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393253] [Frederick Rein] [Entered: 12/21/2016 03:19 PM] (2)
Dec 21, 2016 4 Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393256] [Frederick Rein] [Entered: 12/21/2016 03:22 PM] (3)
Dec 21, 2016 5 Entry of appearance for Joshua A. Whitehill as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393262] [Joshua Whitehill] [Entered: 12/21/2016 03:26 PM] (2)
Dec 21, 2016 6 Entry of appearance for Ira J. Levy as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393266] [Ira Levy] [Entered: 12/21/2016 03:30 PM] (2)
Dec 21, 2016 7 Entry of appearance for Michael B. Cottler as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/21/2016 by email. [393268] [Michael Cottler] [Entered: 12/21/2016 03:34 PM] (2)
Dec 16, 2016 1 Appeal docketed. Received: 12/15/2016. [391739]Entry of Appearance due 12/30/2016. Certificate of Interest is due on 12/30/2016. Docketing Statement due 12/30/2016. Appellant's brief is due 02/14/2017. [AT] [Entered: 12/16/2016 11:01 AM] (27)
Menu